pramipexole has been researched along with Inflammation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abdel Baky, NA; Al-Najjar, AH; Elariny, HA; Mohammed, AA; Sallam, AS | 1 |
Coelho, ID; Cunha, MP; Dafre, AL; de Souza, LF; Dos Santos, AR; Dutra, RC; Junqueira, SC; Lieberknecht, V; Rodrigues, AL | 1 |
Akbartabar Touri, M; Delaviz, H; Ghavamzadeh, M; Jafari Barmak, M; Parishani, M; Sadeghi, H; Zarezade, V | 1 |
Iravani, MM; Jenner, P; Leung, CC; Rose, S; Sadeghian, M; Schapira, AH; Tel, BC | 1 |
4 other study(ies) available for pramipexole and Inflammation
Article | Year |
---|---|
Pramipexole and Lactoferrin ameliorate Cyclophosphamide-Induced haemorrhagic cystitis via targeting Sphk1/S1P/MAPK, TLR-4/NF-κB, and NLRP3/caspase-1/IL-1β signalling pathways and modulating the Nrf2/HO-1 pathway.
Topics: Animals; bcl-2-Associated X Protein; Caspase 1; Caspase 3; Cyclophosphamide; Cystitis; Cytokines; Inflammation; Interleukin-6; Lactoferrin; Male; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pramipexole; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
Antidepressant-like effect of pramipexole in an inflammatory model of depression.
Topics: Animals; Benzothiazoles; Brain; Depression; Disease Models, Animal; Dopamine Agonists; Female; Glial Fibrillary Acidic Protein; Illness Behavior; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Locomotion; Malondialdehyde; Mice; Pramipexole; Swimming; Time Factors; Tyrosine | 2017 |
Pramipexole reduces inflammation in the experimental animal models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Benzothiazoles; Carrageenan; Disease Models, Animal; Inflammation; Male; Mice; Parkinson Disease, Secondary; Pramipexole; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2017 |
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Topics: Amphetamine; Animals; Behavior, Animal; Benzothiazoles; Cell Count; Cell Death; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Interactions; Inflammation; Injections, Subcutaneous; Lipopolysaccharides; Male; Motor Activity; Neurons; Pramipexole; Rats; Rats, Wistar; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2008 |